Atlas Trials

Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)

Clinical trial NCT01434381 · COMPLETED

Trial details

NCT number
NCT01434381
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malaria
Start date
2011-08-01
Primary completion
2013-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.